Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results

Archives of Surgery

Volumn 141, Issue 6, 2006, Pages 552-557

  Goldstein, Richard E ^a,b   Carter II, William M ^a,b   Fleming, Muffin ^a,b   Bumpous, Jeffrey ^a,b   Lentsch, Eric ^a,b   Rice, Michael ^a   Flynn, Michael ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CANCER LOCALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PATIENT MONITORING; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT FAILURE; BLOOD SAMPLING; DIAGNOSTIC ERROR; NOTE; PREOPERATIVE EVALUATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOMA; ALGORITHMS; FEMALE; HUMANS; HYPERPARATHYROIDISM; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 33745239775     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.6.552     Document Type: Article

References (22)

1. Auguste LJ, Attie JN, Schnaap D. Initial failure of surgical exploration in patients with primary hyperparathyroidism. Am J Surg. 1990;160:333-336.
2. van Heerden JA, Grant CS. Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg. 1991;15:688-692.
3. Denham DW, Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg. 1998;186:293-305.
4. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperative nuclear mapping. Surgery. 1997;122:998-1004.
5. Goldstein RE, Blevins L, Delbeke D, Martin WH. Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism. Ann Surg. 2000;231:732-742.
6. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126:1023-1029.
7. Goldstein RE, Billheimer D, Martin W, Richards K. Sestamibi scanning and minimally invasive radioguided parathyroidectomy without intraoperative parathyroid hormone measurement. Ann Surg. 2003;237:722-731.
8. Norman J, Denham D. Minimally invasive radioguided parathyroidectomy in the reoperative neck. Surgery. 1998;124:1088-1093.
9. Irvin GLI, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162:299-302.
10. Irvin GL III, Prudhomme DL, Deriso GT, Stakianakis G, Chandarlapaty SKC. A new approach to parathyroidectomy. Ann Surg. 1994;219:574-581.
11. Carty SE, Worsey J, Virgi MA, Brown ML, Watson CG. Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery. 1997;122:1107-1116.
12. Udelsman R, Donovan PI, Sokoll LJ. One hundred consecutive minimally invasive parathyroid explorations. Ann Surg. 2000;232:331-339.
13. Flynn MB, Bumpous JM, Schill K, McMasters KM. Minimally invasive radioguided parathyroidectomy. J Am Coll Surg. 2000;191:24-31.
14. Irvin GL III, Carneiro DM, Solorzano CS. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg. 2004;239:704-708.
15. Arveschoug AK, Bertelsen H, Vammen B. Presurgical localization of abnormal parathyroid glands using a single injection of Tc-99m sestamibi: comparison of high-resolution parallel-hole and pinhole collimators, and interobserver and intraobserver variation. Clin Nucl Med. 2002;27:249-254.
16. Merlino JI, Ko K, Minotti A, McHenry CR. The false negative technetium-99msestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg. 2003;69:225-230.
17. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidism: Mayo Clinic experience. Arch Surg. 2005;140:472-479.
18. Solorzano CC, Lee TM, Ramirez MC, Carneiro DM, Irvin GL. Surgeon-performed ultrasound improves localization of abnormal parathyroid glands. Am Surg. 2005;71:557-562.
19. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg. 2002;235:665-672.
20. Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery. 2004;136:872-880.
21. Royal RE, Delpassand ES, Shapiro SE, et al. Improving the yield in preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression. Surgery. 2002;132:968-975.
22. Friedman K, Somervell H, Patel P, et al. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery. 2004;136:1199-1204.